CytomX Therapeutics, Inc(NASDAQ:CTMX) 
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (AD...
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 0.55
H 0.55
L 0.45
C 0.46
V 2,041,757
10EMA 0.46
20EMA 0.46
60EMA 0.46
120EMA 0.46
250EMA 0.46